Rania Itani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Rania Itani has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Samar Karout
Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, P.O. Box: 11-5020, Riad El Solh, Beirut, 1107 2809, Lebanon.
12 shared publications Carole Dib
Lebanese Hospital Geitaoui University Medical Center
10 shared publications- Hani M. J. Khojah
Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, Madinah, Kingdom of Saudi Arabia
9 shared publications Abdalla El-Lakany
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon
8 shared publications- Deema Rahme
Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon
7 shared publications Diala Tlayss
Affiliation Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon
7 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (11) , e0361969
Assessment of the appropriateness of stress ulcer prophylaxis practice among hospitalized patients across Lebanese hospitals: A multicenter prospective study
Background: Stress ulcer prophylaxis (SUP) is recommended for critically ill patients at high risk of stress-related gastrointestinal bleeding. Despite established guideline recommendations, inappropriate use of acid suppressant medications (ASMs), particularly proton pump inhibitors (PPIs), remains common worldwide and may expose patients to unnecessary adverse effects and increased healthcare costs. This study aimed to assess the appropriateness of SUP prescribing practices among hospitalized patients across Lebanese hospitals, focusing on indication, choice of pharmacologic agent, dosing regimen, route of administration, duration of therapy, discharge prescribing, and factors associated with inappropriate SUP practice. Methods: A multicenter prospective study was conducted between April 20 and May 22, 2026, across ten tertiary-care hospitals in different regions of Lebanon. Adult patients (≥18 years) admitted to Internal Medicine Unit, Intensive Care Unit (ICU), or Coronary Care Unit wards were assessed for the appropriateness of SUP, regardless of whether ASMs were prescribed. The appropriateness of SUP practice was evaluated according to the Society of Critical Care Medicine and American Society of Health-System Pharmacists (SCCM/ASHP) 2024 and ASHP 1999 guidelines. Multivariable logistic regression was performed to identify factors associated with inappropriate SUP practice. Results: A total of 552 patients were enrolled, with a mean age of 64.3 ± 18.5 years, and 58.7% were male. According to the SCCM/ASHP 2024 and ASHP 1999 guidelines, 90.8% and 77.2% of patients, respectively, were not eligible for SUP. Omeprazole was the most frequently prescribed agent (75.4%), and PPIs were used in all SUP prescriptions. Among patients admitted to ICU, 11.2% continued receiving ASMs after the SUP indication had resolved or following ICU transfer without a persisting indication. Overall, SUP practice was inappropriate in 77.9% of patients. Multivariable analysis demonstrated that anticoagulant therapy was associated with higher odds of inappropriate SUP practice (AOR = 2.78, 95% CI = 1.35–5.74, P = 0.006). Conclusions: Inappropriate SUP practice is highly prevalent among hospitalized patients in Lebanon, largely due to prescribing without guideline-based indications. Inappropriate continuation after resolution of the SUP indication or ICU transfer was also observed. Strengthening adherence to evidence-based recommendations through stewardship programs, prescribing audits, standardized protocols, and updated national guidance may help optimize SUP use and improve patient care.
- 6 November 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (11) , e0361969
Open AccessAssessment of the appropriateness of stress ulcer prophylaxis practice among hospitalized patients across Lebanese hospitals: A multicenter prospective study
Background: Stress ulcer prophylaxis (SUP) is recommended for critically ill patients at high risk of stress-related gastrointestinal bleeding. Despite established guideline recommendations, inappropriate use of acid suppressant medications (ASMs), particularly proton pump inhibitors (PPIs), remains common worldwide and may expose patients to unnecessary adverse effects and increased healthcare costs. This study aimed to assess the appropriateness of SUP prescribing practices among hospitalized patients across Lebanese hospitals, focusing on indication, choice of pharmacologic agent, dosing regimen, route of administration, duration of therapy, discharge prescribing, and factors associated with inappropriate SUP practice. Methods: A multicenter prospective study was conducted between April 20 and May 22, 2026, across ten tertiary-care hospitals in different regions of Lebanon. Adult patients (≥18 years) admitted to Internal Medicine Unit, Intensive Care Unit (ICU), or Coronary Care Unit wards were assessed for the appropriateness of SUP, regardless of whether ASMs were prescribed. The appropriateness of SUP practice was evaluated according to the Society of Critical Care Medicine and American Society of Health-System Pharmacists (SCCM/ASHP) 2024 and ASHP 1999 guidelines. Multivariable logistic regression was performed to identify factors associated with inappropriate SUP practice. Results: A total of 552 patients were enrolled, with a mean age of 64.3 ± 18.5 years, and 58.7% were male. According to the SCCM/ASHP 2024 and ASHP 1999 guidelines, 90.8% and 77.2% of patients, respectively, were not eligible for SUP. Omeprazole was the most frequently prescribed agent (75.4%), and PPIs were used in all SUP prescriptions. Among patients admitted to ICU, 11.2% continued receiving ASMs after the SUP indication had resolved or following ICU transfer without a persisting indication. Overall, SUP practice was inappropriate in 77.9% of patients. Multivariable analysis demonstrated that anticoagulant therapy was associated with higher odds of inappropriate SUP practice (AOR = 2.78, 95% CI = 1.35–5.74, P = 0.006). Conclusions: Inappropriate SUP practice is highly prevalent among hospitalized patients in Lebanon, largely due to prescribing without guideline-based indications. Inappropriate continuation after resolution of the SUP indication or ICU transfer was also observed. Strengthening adherence to evidence-based recommendations through stewardship programs, prescribing audits, standardized protocols, and updated national guidance may help optimize SUP use and improve patient care.
- Open Access
- 27 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354807
Prevalence, risk factors, and management practices of premenstrual syndrome among female university students in Lebanon: An observational cross-sectional study
Background: Premenstrual syndrome (PMS) is common among women of reproductive age and may impair quality of life, academic performance, and social functioning. In Lebanon, data on PMS and its management among female university students remain limited. This study aimed to estimate the prevalence of PMS among female university students in Lebanon, identify risk factors, and recognize adopted management practices and their perceived effectiveness. Methods: An observational cross-sectional study was conducted among female students at Beirut Arab University, Lebanon, between April 20 and May 8, 2026. Data were collected using a self-administered questionnaire assessing sociodemographic, menstrual, lifestyle, behavioral, psychosocial, and management-related factors. Premenstrual symptoms, social media addiction, and perceived stress were assessed using the Premenstrual Symptoms Screening Tool, Bergen Social Media Addiction Scale, and Perceived Stress Scale-4, respectively. Binary logistic regression was used to identify factors associated with moderate-to-severe PMS and premenstrual dysphoric disorder (PMDD). Results: Among 1,062 participants, 497 participants screened positive for moderate-to-severe PMS (46.8%), and 175 had symptoms consistent with PMDD based on the PSST (16.5%). The most frequently reported moderate-to-severe symptoms were physical symptoms (69.7%), fatigue or lack of energy (68.8%), depressed mood or hopelessness (67.8%), and overeating or food cravings (66.2%). Academic absenteeism was reported by 37.2%. More than one-third of the participants with moderate-to-severe PMS and PMDD (39%) reported using pharmacological management practices, mainly non-steroidal anti-inflammatory drugs. However, less than half of medication users perceived these treatments as being very effective (45.8%). Higher odds of moderate-to-severe PMS were observed among current smokers (AOR = 1.61, P = 0.003), those with heavy menstrual bleeding (AOR = 1.58, P = 0.03), high meal skipping (AOR = 1.38, P = 0.03), high fast-food consumption (AOR = 1.34, P = 0.04), higher social media addiction scores (AOR = 1.31, P < 0.001), and higher perceived stress scores (AOR = 1.48, P < 0.001). Conclusion: PMS was common among female university students in Lebanon and a considerable proportion experienced PMDD. In fact, lifestyle, behavioral, and psychosocial factors were associated with moderate-to-severe symptoms, highlighting the need for university-based awareness, screening, and counseling strategies that address modifiable risk factors and support appropriate management of premenstrual symptoms.
- 27 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354807
Open AccessPrevalence, risk factors, and management practices of premenstrual syndrome among female university students in Lebanon: An observational cross-sectional study
Background: Premenstrual syndrome (PMS) is common among women of reproductive age and may impair quality of life, academic performance, and social functioning. In Lebanon, data on PMS and its management among female university students remain limited. This study aimed to estimate the prevalence of PMS among female university students in Lebanon, identify risk factors, and recognize adopted management practices and their perceived effectiveness. Methods: An observational cross-sectional study was conducted among female students at Beirut Arab University, Lebanon, between April 20 and May 8, 2026. Data were collected using a self-administered questionnaire assessing sociodemographic, menstrual, lifestyle, behavioral, psychosocial, and management-related factors. Premenstrual symptoms, social media addiction, and perceived stress were assessed using the Premenstrual Symptoms Screening Tool, Bergen Social Media Addiction Scale, and Perceived Stress Scale-4, respectively. Binary logistic regression was used to identify factors associated with moderate-to-severe PMS and premenstrual dysphoric disorder (PMDD). Results: Among 1,062 participants, 497 participants screened positive for moderate-to-severe PMS (46.8%), and 175 had symptoms consistent with PMDD based on the PSST (16.5%). The most frequently reported moderate-to-severe symptoms were physical symptoms (69.7%), fatigue or lack of energy (68.8%), depressed mood or hopelessness (67.8%), and overeating or food cravings (66.2%). Academic absenteeism was reported by 37.2%. More than one-third of the participants with moderate-to-severe PMS and PMDD (39%) reported using pharmacological management practices, mainly non-steroidal anti-inflammatory drugs. However, less than half of medication users perceived these treatments as being very effective (45.8%). Higher odds of moderate-to-severe PMS were observed among current smokers (AOR = 1.61, P = 0.003), those with heavy menstrual bleeding (AOR = 1.58, P = 0.03), high meal skipping (AOR = 1.38, P = 0.03), high fast-food consumption (AOR = 1.34, P = 0.04), higher social media addiction scores (AOR = 1.31, P < 0.001), and higher perceived stress scores (AOR = 1.48, P < 0.001). Conclusion: PMS was common among female university students in Lebanon and a considerable proportion experienced PMDD. In fact, lifestyle, behavioral, and psychosocial factors were associated with moderate-to-severe symptoms, highlighting the need for university-based awareness, screening, and counseling strategies that address modifiable risk factors and support appropriate management of premenstrual symptoms.
- Open Access
- 8 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0350837
Multidrug resistance and inappropriate empiric therapy as predictors of hospital stay in diabetic foot infections
Objectives: This study explored the causative pathogens, resistance patterns, and treatment appropriateness for diabetic foot infections (DFI) at a tertiary care center in Jordan. Methods: A retrospective review was conducted on 234 patients diagnosed with DFIs at a tertiary care center in Jordan. Data collected included patient demographics, diabetes history, infection severity, culture results, and antibiotic treatment details. Bacterial isolates were classified as multidrug-resistant (MDR) or non-MDR based on standard definitions. Therapy was considered appropriate if at least one antibiotic given within the first 48 hours of admission covered all identified pathogens and was administered with the correct dosage, formulation, and route. Statistical analyses examined the relationship between resistance patterns, treatment adequacy, and hospital stay duration. Results: The most frequently isolated bacterium was Staphylococcus aureus , identified in 117 cases (50.0%), including MRSA (n = 46, 19.6%) and MSSA (n = 71, 30.3%). This was followed by Escherichia coli in 33 cases (14.1%) and Pseudomonas aeruginosa in 32 cases (13.7%). MDR organisms accounted for 152 infections (65%). Empiric therapy was deemed appropriate in 111 patients (47.4%), inappropriate in 74 (31.6%), and not assessable due to missing data in 49 (20.9%). Following culture and susceptibility results, antibiotics in 87 cases (37.2%) remained unchanged. In multivariate analysis, only infection severity was significantly associated with prolonged hospitalization (β = −0.161, P = 0.034). Conclusion: MDR organisms were common in DFIs but not significantly associated with prolonged hospitalization. Infection severity was the key predictor of length of stay. These findings highlight the importance of early infection assessment, appropriate empirical therapy based on local resistance patterns, and robust antibiotic stewardship.
- 8 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0350837
Open AccessMultidrug resistance and inappropriate empiric therapy as predictors of hospital stay in diabetic foot infections
Objectives: This study explored the causative pathogens, resistance patterns, and treatment appropriateness for diabetic foot infections (DFI) at a tertiary care center in Jordan. Methods: A retrospective review was conducted on 234 patients diagnosed with DFIs at a tertiary care center in Jordan. Data collected included patient demographics, diabetes history, infection severity, culture results, and antibiotic treatment details. Bacterial isolates were classified as multidrug-resistant (MDR) or non-MDR based on standard definitions. Therapy was considered appropriate if at least one antibiotic given within the first 48 hours of admission covered all identified pathogens and was administered with the correct dosage, formulation, and route. Statistical analyses examined the relationship between resistance patterns, treatment adequacy, and hospital stay duration. Results: The most frequently isolated bacterium was Staphylococcus aureus , identified in 117 cases (50.0%), including MRSA (n = 46, 19.6%) and MSSA (n = 71, 30.3%). This was followed by Escherichia coli in 33 cases (14.1%) and Pseudomonas aeruginosa in 32 cases (13.7%). MDR organisms accounted for 152 infections (65%). Empiric therapy was deemed appropriate in 111 patients (47.4%), inappropriate in 74 (31.6%), and not assessable due to missing data in 49 (20.9%). Following culture and susceptibility results, antibiotics in 87 cases (37.2%) remained unchanged. In multivariate analysis, only infection severity was significantly associated with prolonged hospitalization (β = −0.161, P = 0.034). Conclusion: MDR organisms were common in DFIs but not significantly associated with prolonged hospitalization. Infection severity was the key predictor of length of stay. These findings highlight the importance of early infection assessment, appropriate empirical therapy based on local resistance patterns, and robust antibiotic stewardship.
- Open Access
- 5 June 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (8) , 103282
Epidemiology, antimicrobial resistance patterns, management, and predictors of mortality in diabetic foot infections in a Lebanese hospital: A retrospective observational study
- 5 June 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (8) , 103282
Open AccessEpidemiology, antimicrobial resistance patterns, management, and predictors of mortality in diabetic foot infections in a Lebanese hospital: A retrospective observational study
- Open Access
- 20 August 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-14
Incidence and risk factors of resistant Pseudomonas aeruginosa infections: a multicenter study in Lebanese tertiary hospitals
The emergence of difficult-to-treat resistant (DTR) Pseudomonas aeruginosa infections poses a significant clinical challenge, characterized by limited treatment options, poor outcomes, and increased morbidity and mortality. DTR P. aeruginosa isolates exhibit resistance to all first-line antibiotics, necessitating the use of less effective or more toxic alternatives. This study estimated the incidence of DTR P. aeruginosa infections in Lebanon and identified the associated risk factors. This retrospective observational study was conducted across four tertiary care centers in Beirut, Lebanon, over a three-year period from 2021 to 2023. Univariate and multivariate logistic regression analyses were performed to identify significant predictors associated with DTR P. aeruginosa infections. A total of 2,639 cases with positive P. aeruginosa isolates were initially screened, with 477 cases meeting the inclusion criteria for analysis. The mean age of the patients was 66.3 ± 17.8 years, and the mean Charlson Comorbidity Index was 4.46 ± 2.43. Nearly half of the infections were nosocomial (47.6%). The most common primary site of infection was the respiratory tract (38.8%), followed by skin and soft tissue (32.7%). The incidence of DTR P. aeruginosa was 15.3%, and the incidence of carbapenem-resistant P. aeruginosa (CRPA) was 29.9%. Binary logistic regression identified three main risk factors for DTR P. aeruginosa infection acquisition: infections occurring during the winter season (adjusted odds ratio [AOR] = 6.08, 95% CI = 2.75–16.13, P < 0.01), intensive care unit stay (AOR = 2.52, 95% CI = 1.28–4.98, P < 0.01), and infections originating from the respiratory tract (AOR = 2.49, 95% CI = 1.04–5.97, P = 0.04). The incidence of DTR P. aeruginosa in Lebanese hospitals is substantial compared to global rates and poses a significant challenge to effective treatment. Urgent measures are required to prevent and mitigate the spread of DTR P. aeruginosa infections. Hospital-based antimicrobial stewardship and infection control programs need to be reinforced, and community-based initiatives should be implemented at the national level. Efforts to combat antimicrobial resistance must be supported by ongoing nationwide annual surveillance.
- 20 August 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-14
Open AccessIncidence and risk factors of resistant Pseudomonas aeruginosa infections: a multicenter study in Lebanese tertiary hospitals
The emergence of difficult-to-treat resistant (DTR) Pseudomonas aeruginosa infections poses a significant clinical challenge, characterized by limited treatment options, poor outcomes, and increased morbidity and mortality. DTR P. aeruginosa isolates exhibit resistance to all first-line antibiotics, necessitating the use of less effective or more toxic alternatives. This study estimated the incidence of DTR P. aeruginosa infections in Lebanon and identified the associated risk factors. This retrospective observational study was conducted across four tertiary care centers in Beirut, Lebanon, over a three-year period from 2021 to 2023. Univariate and multivariate logistic regression analyses were performed to identify significant predictors associated with DTR P. aeruginosa infections. A total of 2,639 cases with positive P. aeruginosa isolates were initially screened, with 477 cases meeting the inclusion criteria for analysis. The mean age of the patients was 66.3 ± 17.8 years, and the mean Charlson Comorbidity Index was 4.46 ± 2.43. Nearly half of the infections were nosocomial (47.6%). The most common primary site of infection was the respiratory tract (38.8%), followed by skin and soft tissue (32.7%). The incidence of DTR P. aeruginosa was 15.3%, and the incidence of carbapenem-resistant P. aeruginosa (CRPA) was 29.9%. Binary logistic regression identified three main risk factors for DTR P. aeruginosa infection acquisition: infections occurring during the winter season (adjusted odds ratio [AOR] = 6.08, 95% CI = 2.75–16.13, P < 0.01), intensive care unit stay (AOR = 2.52, 95% CI = 1.28–4.98, P < 0.01), and infections originating from the respiratory tract (AOR = 2.49, 95% CI = 1.04–5.97, P = 0.04). The incidence of DTR P. aeruginosa in Lebanese hospitals is substantial compared to global rates and poses a significant challenge to effective treatment. Urgent measures are required to prevent and mitigate the spread of DTR P. aeruginosa infections. Hospital-based antimicrobial stewardship and infection control programs need to be reinforced, and community-based initiatives should be implemented at the national level. Efforts to combat antimicrobial resistance must be supported by ongoing nationwide annual surveillance.
- Open Access
Prevalence, Appropriateness, and Outcomes of Colistin Use in Multidrug-Resistant Pseudomonas aeruginosa Infections: Insights from Hospital Data
Background and Objectives: This study aimed to assess the prevalence of colistin prescriptions among patients with multidrug-resistant (MDR) Pseudomonas aeruginosa (P. aeruginosa) infections admitted to a tertiary teaching hospital in Jordan. Additionally, the study evaluated the appropriateness of colistin prescriptions and assessed resistance levels of this strain. Materials and Methods: In this retrospective study, adult patients who were infected with MDR P. aeruginosa and were admitted to Jordan University Hospital between January 2018 and March 2024 were included. Data on demographics, clinical characteristics, sources of infection, antibiotic therapy, and clinical outcomes were collected. Results: Out of the 85 patients who met the inclusion criteria for having MDR P. aeruginosa, colistin was administered to 16 patients (18.8%). Notably, approximately two-thirds (68.7%) of the isolates from patients who received colistin were classified as extensively drug-resistant (XDR). Among the isolates, 15 out of 16 (93.8%) were resistant to both ciprofloxacin and imipenem. Among the patients requiring colistin, five (31.3%) discontinued therapy, while two (12.5%) remained on colistin despite the availability of safer alternatives. No significant difference was observed in 30-day all-cause mortality between patients treated with colistin (0%) and those who were not (4.3%, p = 1.00). Similarly, the incidence of acute kidney injury did not differ significantly between the colistin group (0%) and the non-colistin group (p = 1.00). No significant difference was found in the hospital stay between colistin-treated patients (median 10.5 days, IQR [5.0–14.0]) and those not treated with colistin (median 13.0 days, IQR [7.0–21.0]), (p = 0.22). Conclusions: This study demonstrated that colistin was selectively initiated in high-risk patients, particularly those with XDR P. aeruginosa. However, its inappropriate continuation despite safer alternatives, as well as its discontinuation when no other options existed, raise concerns about antibiotic de-escalation practices. Interestingly, no significant differences in mortality or acute kidney injury were observed between patients who were treated with colistin and those who were not. These findings emphasize the need for antimicrobial stewardship programs and highlight the importance of large-scale trials to evaluate colistin’s efficacy and safety in MDR infections.
Open AccessPrevalence, Appropriateness, and Outcomes of Colistin Use in Multidrug-Resistant Pseudomonas aeruginosa Infections: Insights from Hospital Data
Background and Objectives: This study aimed to assess the prevalence of colistin prescriptions among patients with multidrug-resistant (MDR) Pseudomonas aeruginosa (P. aeruginosa) infections admitted to a tertiary teaching hospital in Jordan. Additionally, the study evaluated the appropriateness of colistin prescriptions and assessed resistance levels of this strain. Materials and Methods: In this retrospective study, adult patients who were infected with MDR P. aeruginosa and were admitted to Jordan University Hospital between January 2018 and March 2024 were included. Data on demographics, clinical characteristics, sources of infection, antibiotic therapy, and clinical outcomes were collected. Results: Out of the 85 patients who met the inclusion criteria for having MDR P. aeruginosa, colistin was administered to 16 patients (18.8%). Notably, approximately two-thirds (68.7%) of the isolates from patients who received colistin were classified as extensively drug-resistant (XDR). Among the isolates, 15 out of 16 (93.8%) were resistant to both ciprofloxacin and imipenem. Among the patients requiring colistin, five (31.3%) discontinued therapy, while two (12.5%) remained on colistin despite the availability of safer alternatives. No significant difference was observed in 30-day all-cause mortality between patients treated with colistin (0%) and those who were not (4.3%, p = 1.00). Similarly, the incidence of acute kidney injury did not differ significantly between the colistin group (0%) and the non-colistin group (p = 1.00). No significant difference was found in the hospital stay between colistin-treated patients (median 10.5 days, IQR [5.0–14.0]) and those not treated with colistin (median 13.0 days, IQR [7.0–21.0]), (p = 0.22). Conclusions: This study demonstrated that colistin was selectively initiated in high-risk patients, particularly those with XDR P. aeruginosa. However, its inappropriate continuation despite safer alternatives, as well as its discontinuation when no other options existed, raise concerns about antibiotic de-escalation practices. Interestingly, no significant differences in mortality or acute kidney injury were observed between patients who were treated with colistin and those who were not. These findings emphasize the need for antimicrobial stewardship programs and highlight the importance of large-scale trials to evaluate colistin’s efficacy and safety in MDR infections.
- Open Access
- 11 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (28) , e43217
Public preparedness and knowledge about emergency medicine: A study across 6 countries
Low health literacy is associated with poor health outcomes, inefficient use of healthcare resources, higher mortality risk, and increased costs. The aim of this research is to explore public awareness and preparedness regarding various treatment options for acute medical events and to assess the competence in assessing the urgency of such medical situations in 6 Middle Eastern countries namely, Jordan, Saudi Arabia, Egypt, Lebanon, Kuwait, and Bahrain. This research involved a cross-sectional survey study design to assess public knowledge and preparedness about emergency medicine using an online questionnaire distributed through accessible online channels between March 1, 2024 until September 11, 2024. A total of 4909 participants were involved in this research. The questionnaire was developed based on a thorough review of existing literature related to public knowledge and public preparedness of emergency medicine. Binary logistic regression analysis was used to identify significant predictors of insufficient and problematic emergency health literacy (EHL) levels. Overall, the most commonly known emergency care service was identifying emergency practice nearby (81.4%). The least commonly known emergency care service was identifying the rescue service (48.1%). The highest degree of difficulty reported by the study participants was the difficulties they face to evaluate when to use emergency medical services (39.6%). The mean public EHL score for the study sample was 2.77 (standard deviation [SD]: 0.44) out of 3. The mean public EHL score ranged between 2.69 (SD: 0.50) for Kuwait and 2.89 (SD: 0.56) for Bahrain. The majority of the study participants (75.1%) demonstrated problematic EHL. Males, young participants aged 24 to 30 years and elderly participants aged 61 years and older, highly educated individuals, high income level individuals, and those who work in the healthcare sector were less likely to have inadequate and problematic EHL levels (P < .05). The findings of the present study indicate limited emergency public EHL among 6 of the Middle Eastern countries, highlighting the need for interventions to promote public knowledge and capabilities. Educational campaigns that promote EHL should target females, those with low education and socioeconomic status, those in age range of 30 to 60 years, and those who do not work in health sector.
- 11 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (28) , e43217
Open AccessPublic preparedness and knowledge about emergency medicine: A study across 6 countries
Low health literacy is associated with poor health outcomes, inefficient use of healthcare resources, higher mortality risk, and increased costs. The aim of this research is to explore public awareness and preparedness regarding various treatment options for acute medical events and to assess the competence in assessing the urgency of such medical situations in 6 Middle Eastern countries namely, Jordan, Saudi Arabia, Egypt, Lebanon, Kuwait, and Bahrain. This research involved a cross-sectional survey study design to assess public knowledge and preparedness about emergency medicine using an online questionnaire distributed through accessible online channels between March 1, 2024 until September 11, 2024. A total of 4909 participants were involved in this research. The questionnaire was developed based on a thorough review of existing literature related to public knowledge and public preparedness of emergency medicine. Binary logistic regression analysis was used to identify significant predictors of insufficient and problematic emergency health literacy (EHL) levels. Overall, the most commonly known emergency care service was identifying emergency practice nearby (81.4%). The least commonly known emergency care service was identifying the rescue service (48.1%). The highest degree of difficulty reported by the study participants was the difficulties they face to evaluate when to use emergency medical services (39.6%). The mean public EHL score for the study sample was 2.77 (standard deviation [SD]: 0.44) out of 3. The mean public EHL score ranged between 2.69 (SD: 0.50) for Kuwait and 2.89 (SD: 0.56) for Bahrain. The majority of the study participants (75.1%) demonstrated problematic EHL. Males, young participants aged 24 to 30 years and elderly participants aged 61 years and older, highly educated individuals, high income level individuals, and those who work in the healthcare sector were less likely to have inadequate and problematic EHL levels (P < .05). The findings of the present study indicate limited emergency public EHL among 6 of the Middle Eastern countries, highlighting the need for interventions to promote public knowledge and capabilities. Educational campaigns that promote EHL should target females, those with low education and socioeconomic status, those in age range of 30 to 60 years, and those who do not work in health sector.
- Open Access
- 12 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0321935
Difficult-to-treat resistant Pseudomonas aeruginosa infections in Lebanese hospitals: Impact on mortality and the role of initial antibiotic therapy
Background: Difficult-to-treat resistant (DTR) Pseudomonas aeruginosa infections have emerged as a significant global public health threat, characterized by limited treatment options and a heightened mortality risk. This study aimed to assess the appropriateness of initial antibiotic therapy, estimate 30-day all-cause mortality, and determine the impact of DTR P. aeruginosa infections on mortality. Methods: A retrospective, multicenter study was conducted at four teaching hospitals in Beirut, Lebanon, between January 2021 and December 2023. The primary outcome was 30-day all-cause mortality. Kaplan-Meier survival analysis was used to assess time-to-mortality, and the log-rank test was applied to compare survival outcomes relative to DTR infections and the appropriateness of initial antibiotic therapy. Multivariable logistic regression was performed to identify predictors of mortality. Results: Out of 2,639 screened cases, 477 patients met the inclusion criteria. Respiratory tract infections accounted for 38.8% of cases. Carbapenem-resistant P. aeruginosa (CRPA) comprised nearly one-third of isolates, and 15.3% were categorized as DTR. The most common empirical antibiotics were piperacillin-tazobactam (33.9%) and meropenem (24.5%). Inappropriate initial antibiotic therapy was observed in 43.8% of cases, with 33.8% of patients receiving antibiotics to which the pathogen was resistant. DTR infections were significantly more likely to be associated with inappropriate therapy (odds ratio [OR] = 4.21, 95% CI = 2.43–7.32, P < 0.001). The 30-day all-cause mortality rate was 14.8%, with a mean time-to-mortality of 13.29 ± 9.81 days. Patients who received inappropriate therapy had a shorter time-to-mortality (11.76 ± 8.80 days) compared to those receiving appropriate therapy (15.46 ± 10.90 days, P = 0.03). Predictors of mortality included DTR P. aeruginosa infection (adjusted odds ratio [AOR] = 2.48, 95% CI = 1.32–4.63, P < 0.01), and inappropriate initial therapy (AOR = 1.40, 95% CI = 1.04–2.35, P < 0.01). Conclusion: DTR P. aeruginosa infections and inappropriate initial antibiotic therapy are associated with increased mortality risk in hospitalized patients.
- 12 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0321935
Open AccessDifficult-to-treat resistant Pseudomonas aeruginosa infections in Lebanese hospitals: Impact on mortality and the role of initial antibiotic therapy
Background: Difficult-to-treat resistant (DTR) Pseudomonas aeruginosa infections have emerged as a significant global public health threat, characterized by limited treatment options and a heightened mortality risk. This study aimed to assess the appropriateness of initial antibiotic therapy, estimate 30-day all-cause mortality, and determine the impact of DTR P. aeruginosa infections on mortality. Methods: A retrospective, multicenter study was conducted at four teaching hospitals in Beirut, Lebanon, between January 2021 and December 2023. The primary outcome was 30-day all-cause mortality. Kaplan-Meier survival analysis was used to assess time-to-mortality, and the log-rank test was applied to compare survival outcomes relative to DTR infections and the appropriateness of initial antibiotic therapy. Multivariable logistic regression was performed to identify predictors of mortality. Results: Out of 2,639 screened cases, 477 patients met the inclusion criteria. Respiratory tract infections accounted for 38.8% of cases. Carbapenem-resistant P. aeruginosa (CRPA) comprised nearly one-third of isolates, and 15.3% were categorized as DTR. The most common empirical antibiotics were piperacillin-tazobactam (33.9%) and meropenem (24.5%). Inappropriate initial antibiotic therapy was observed in 43.8% of cases, with 33.8% of patients receiving antibiotics to which the pathogen was resistant. DTR infections were significantly more likely to be associated with inappropriate therapy (odds ratio [OR] = 4.21, 95% CI = 2.43–7.32, P < 0.001). The 30-day all-cause mortality rate was 14.8%, with a mean time-to-mortality of 13.29 ± 9.81 days. Patients who received inappropriate therapy had a shorter time-to-mortality (11.76 ± 8.80 days) compared to those receiving appropriate therapy (15.46 ± 10.90 days, P = 0.03). Predictors of mortality included DTR P. aeruginosa infection (adjusted odds ratio [AOR] = 2.48, 95% CI = 1.32–4.63, P < 0.01), and inappropriate initial therapy (AOR = 1.40, 95% CI = 1.04–2.35, P < 0.01). Conclusion: DTR P. aeruginosa infections and inappropriate initial antibiotic therapy are associated with increased mortality risk in hospitalized patients.
- Open Access
- 28 April 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-15
Management practices and mortality predictors among Klebsiella pneumoniae infections across Lebanese hospitals: a multicenter retrospective study
Background: Klebsiella pneumoniae is a significant cause of both community-acquired and nosocomial infections, leading to high morbidity and mortality rates. The increasing antimicrobial resistance among K. pneumoniae strains poses a critical challenge to effective treatment. This study aimed to assess the appropriateness of initial antimicrobial therapy, determine the 30-day all-cause mortality rate, and identify predictors of mortality among patients infected with K. pneumoniae in Lebanese hospitals. Methods: A multicenter retrospective observational study was conducted across three university hospitals in Beirut, Lebanon. The study included hospitalized adult patients with confirmed K. pneumoniae infections. Kaplan-Meier survival analysis and log-rank tests were used to analyze time-to-mortality. Binary logistic regression was performed to identify predictors of mortality. Results: Of 2,655 cases screened, 410 patients were enrolled, and 395 cases were included in the final analysis of the 30-day mortality after excluding those lost to follow-up. Nearly one-third of the isolates (36.8%) were extended-spectrum β-lactamase (ESBL)-producing, while 6.8% were carbapenem-resistant K. pneumoniae (CRKP). The most commonly prescribed empirical antibiotics were meropenem (31.7%), amikacin (28.5%), and ceftriaxone (22.2%). Around one-third of the patients (32.9%) received inappropriate initial antimicrobial therapy. The 30-day mortality rate was 14.4%. Main predictors significantly associated with mortality in patients with K. pneumoniae infection were solid cancer (adjusted odds ratio [AOR] = 7.82, P < 0.01), coronary artery disease (AOR = 4.81, P = 0.01), age ≥ 65 years (AOR = 4.22, P = 0.02), type II diabetes mellitus (AOR = 3.96, P = 0.01), receiving inappropriate initial antimicrobial therapy (AOR = 2.96, P = 0.02), infection with CRKP isolates (AOR = 2.53, P = 0.03), and having a higher Charlson comorbidity index (AOR = 1.61, P = 0.001). Conclusions: The study highlights the critical need for effective antimicrobial stewardship and tailored infection control protocols to mitigate the high resistance rates and improve patient outcomes in Lebanon. Emphasis should be placed on enhancing the monitoring of local resistance patterns and using these data to guide the selection of appropriate empirical therapy to reduce mortality associated with K. pneumoniae infections.
- 28 April 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-15
Open AccessManagement practices and mortality predictors among Klebsiella pneumoniae infections across Lebanese hospitals: a multicenter retrospective study
Background: Klebsiella pneumoniae is a significant cause of both community-acquired and nosocomial infections, leading to high morbidity and mortality rates. The increasing antimicrobial resistance among K. pneumoniae strains poses a critical challenge to effective treatment. This study aimed to assess the appropriateness of initial antimicrobial therapy, determine the 30-day all-cause mortality rate, and identify predictors of mortality among patients infected with K. pneumoniae in Lebanese hospitals. Methods: A multicenter retrospective observational study was conducted across three university hospitals in Beirut, Lebanon. The study included hospitalized adult patients with confirmed K. pneumoniae infections. Kaplan-Meier survival analysis and log-rank tests were used to analyze time-to-mortality. Binary logistic regression was performed to identify predictors of mortality. Results: Of 2,655 cases screened, 410 patients were enrolled, and 395 cases were included in the final analysis of the 30-day mortality after excluding those lost to follow-up. Nearly one-third of the isolates (36.8%) were extended-spectrum β-lactamase (ESBL)-producing, while 6.8% were carbapenem-resistant K. pneumoniae (CRKP). The most commonly prescribed empirical antibiotics were meropenem (31.7%), amikacin (28.5%), and ceftriaxone (22.2%). Around one-third of the patients (32.9%) received inappropriate initial antimicrobial therapy. The 30-day mortality rate was 14.4%. Main predictors significantly associated with mortality in patients with K. pneumoniae infection were solid cancer (adjusted odds ratio [AOR] = 7.82, P < 0.01), coronary artery disease (AOR = 4.81, P = 0.01), age ≥ 65 years (AOR = 4.22, P = 0.02), type II diabetes mellitus (AOR = 3.96, P = 0.01), receiving inappropriate initial antimicrobial therapy (AOR = 2.96, P = 0.02), infection with CRKP isolates (AOR = 2.53, P = 0.03), and having a higher Charlson comorbidity index (AOR = 1.61, P = 0.001). Conclusions: The study highlights the critical need for effective antimicrobial stewardship and tailored infection control protocols to mitigate the high resistance rates and improve patient outcomes in Lebanon. Emphasis should be placed on enhancing the monitoring of local resistance patterns and using these data to guide the selection of appropriate empirical therapy to reduce mortality associated with K. pneumoniae infections.
- Open Access
- 23 April 2025
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 6, 1001312
Evaluation of empiric therapy appropriateness, resistance patterns, and mortality in Pseudomonas aeruginosa infections in Jordan
Aim: This study aimed to investigate the susceptibility patterns of Pseudomonas aeruginosa strains, examine infection characteristics, and evaluate the appropriateness of empiric antibiotic therapy. Additionally, the study sought to identify factors influencing 30-day all-cause mortality in patients with Pseudomonas aeruginosa infections. Methods: This was a retrospective study conducted at Jordan University Hospital from January 2018 to March 2024. Adult patients (≥ 18 years) with confirmed Pseudomonas aeruginosa infections were included. Data were collected from medical records, focusing on demographics, infection characteristics, antibiotic treatment, and outcomes. The susceptibility patterns of Pseudomonas aeruginosa isolates were classified as multidrug-resistant (MDR) or non-MDR. Logistic regression was used to identify factors associated with 30-day mortality. Results: A total of 210 patients were included in the study, with 106 males (50.5%) and 104 females (49.5%). The majority of infections were community-acquired (n = 178, 84.8%), with the respiratory tract being the most common infection site (n = 81, 38.6%). Nearly half of the Pseudomonas aeruginosa isolates were MDR (n = 99, 47.1%). Empiric antibiotic therapy was administered to all patients, with imipenem-cilastatin (55.7%), vancomycin (35.7%), and piperacillin-tazobactam (26.7%) being the most commonly used antibiotics. Of the 210 patients, 32.4% (n = 68) received inappropriate empiric therapy. The 30-day all-cause mortality rate was 4.9% (n = 10). Multivariate analysis revealed that non-localized infections, such as bacteremia and sepsis, were strongly associated with increased mortality [adjusted odds ratio (AOR) = 17.455, P < 0.001]. Conclusions: This study highlights the high prevalence of MDR Pseudomonas aeruginosa infections, especially in community-acquired cases, and emphasizes the need for improved antimicrobial stewardship. The significant proportion of patients (32.4%) receiving inappropriate empiric therapy calls for better guidance in antibiotic prescribing practices. The key predictor of mortality was infection localization, indicating the importance of early intervention for systemic infections to reduce mortality rates.
- 23 April 2025
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 6, 1001312
Open AccessEvaluation of empiric therapy appropriateness, resistance patterns, and mortality in Pseudomonas aeruginosa infections in Jordan
Aim: This study aimed to investigate the susceptibility patterns of Pseudomonas aeruginosa strains, examine infection characteristics, and evaluate the appropriateness of empiric antibiotic therapy. Additionally, the study sought to identify factors influencing 30-day all-cause mortality in patients with Pseudomonas aeruginosa infections. Methods: This was a retrospective study conducted at Jordan University Hospital from January 2018 to March 2024. Adult patients (≥ 18 years) with confirmed Pseudomonas aeruginosa infections were included. Data were collected from medical records, focusing on demographics, infection characteristics, antibiotic treatment, and outcomes. The susceptibility patterns of Pseudomonas aeruginosa isolates were classified as multidrug-resistant (MDR) or non-MDR. Logistic regression was used to identify factors associated with 30-day mortality. Results: A total of 210 patients were included in the study, with 106 males (50.5%) and 104 females (49.5%). The majority of infections were community-acquired (n = 178, 84.8%), with the respiratory tract being the most common infection site (n = 81, 38.6%). Nearly half of the Pseudomonas aeruginosa isolates were MDR (n = 99, 47.1%). Empiric antibiotic therapy was administered to all patients, with imipenem-cilastatin (55.7%), vancomycin (35.7%), and piperacillin-tazobactam (26.7%) being the most commonly used antibiotics. Of the 210 patients, 32.4% (n = 68) received inappropriate empiric therapy. The 30-day all-cause mortality rate was 4.9% (n = 10). Multivariate analysis revealed that non-localized infections, such as bacteremia and sepsis, were strongly associated with increased mortality [adjusted odds ratio (AOR) = 17.455, P < 0.001]. Conclusions: This study highlights the high prevalence of MDR Pseudomonas aeruginosa infections, especially in community-acquired cases, and emphasizes the need for improved antimicrobial stewardship. The significant proportion of patients (32.4%) receiving inappropriate empiric therapy calls for better guidance in antibiotic prescribing practices. The key predictor of mortality was infection localization, indicating the importance of early intervention for systemic infections to reduce mortality rates.